Insider · CIK 0001352620

Hasnain Faheem

CIK 0001352620 Name as filed on the most recent filing

Filed as Hasnain Faheem (21)

56 transaction lines · from 21 filings · filed 2006-10-03 to 2025-12-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

56 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-12-09 S, Open-market sale Kura Oncology, Inc.KURA 109,764, disposed Open Form 4 filing 0001193125-25-314154
2025-03-21 S, Open-market sale Kura Oncology, Inc.KURA 181,456, disposed Open Form 4 filing 0000950170-25-043903
2024-06-21 P, Open-market purchase Gossamer Bio, Inc.GOSS 250,282, acquired Open Form 4 filing 0001728117-24-000076
2024-03-27 S, Open-market sale Gossamer Bio, Inc.GOSS 26,773, disposed Open Form 4 filing 0001728117-24-000037
2023-08-11 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 299,990, acquired Open Form 4 filing 0001209191-23-045653
2023-03-22 P, Open-market purchase Gossamer Bio, Inc.GOSS 503,580, acquired Open Form 4 filing 0001728117-23-000018
2023-03-21 P, Open-market purchase Gossamer Bio, Inc.GOSS 322,324, acquired Open Form 4 filing 0001728117-23-000018
2023-03-20 P, Open-market purchase Gossamer Bio, Inc.GOSS 174,486, acquired Open Form 4 filing 0001728117-23-000018
2022-07-15 P, Open-market purchase Gossamer Bio, Inc.GOSS 999,998, acquired Open Form 4 filing 0001728117-22-000059
2022-03-23 S, Open-market sale Gossamer Bio, Inc.GOSS 169,697, disposed Open Form 4 filing 0001728117-22-000031
2020-10-14 P, Open-market purchase Gossamer Bio, Inc.GOSS 999,995, acquired Open Form 4 filing 0001209191-20-054841
2019-09-27 P, Open-market purchase Gossamer Bio, Inc.GOSS 167,980, acquired Open Form 4 filing 0001209191-19-050928
2019-05-30 P, Open-market purchase Tocagen IncTOCA 3 lines 200,315, acquired Open Form 4 filing 0001209191-19-033882
2018-09-13 S, Open-market sale Vital Therapies IncVTL 2 lines 77,679, disposed Open Form 4 filing 0001280776-18-000088
2017-09-14 P, Open-market purchase Vital Therapies IncVTL 247,870, acquired Open Form 4 filing 0001280776-17-000092
2017-04-19 P, Open-market purchase Tocagen IncTOCA 1,000,000, acquired Open Form 4 filing 0001209191-17-027904
2016-08-12 P, Open-market purchase Vital Therapies IncVTL 699,999, acquired Open Form 4 filing 0001280776-16-000016
2014-11-11 S, Open-market sale Receptos, Inc.RCPT 6,888,713, disposed Open Form 4 filing 0001209191-14-068344
2014-11-10 S, Open-market sale Receptos, Inc.RCPT 15,005,044, disposed Open Form 4 filing 0001209191-14-068344
2008-07-09 S, Open-market sale Biogen Idec Inc.BIIB 2 lines 2,286,605, disposed Open Form 4 filing 0001209191-08-042084
2008-04-08 S, Open-market sale Biogen Idec Inc.BIIB 25 lines 414,208, disposed Open Form 4 filing 0001209191-08-023622
2007-05-23 S, Open-market sale Biogen Idec Inc.BIIB 364,854, disposed Open Form 4 filing 0001209191-07-032701

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 14
  • Open-market sale 42
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Hasnain Faheem, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001352620

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.